![Mark Andersen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mark Andersen
Keine laufenden Positionen mehr
Profil
Mark Andersen worked as an Investments Director-Pension Plan at Eli Lilly & Co. from 2004 to 2015.
He then served as Vice President-Finance & Controller at MiMedx, Inc. in 2015 and 2016.
Mark also worked as an Auditor at Deloitte Development LLC from 1998 to 1999 and at KPMG US LLP from 1996 to 1998.
He held the position of Chief Financial Officer & VP-Administration at Indiana Biosciences Research Institute from 2016 to 2022.
Currently, Mark is the Chief Financial Officer at FibroBiologics, Inc. since 2022.
Mr. Andersen completed his undergraduate and graduate degrees at Southern Utah University and holds an MBA from Stephen M.
Ross School of Business.
Ehemalige bekannte Positionen von Mark Andersen
| Unternehmen | Position | Ende |
|---|---|---|
| FIBROBIOLOGICS, INC. | Finanzdirektor/CFO | 28.10.2024 |
Indiana Biosciences Research Institute
 Indiana Biosciences Research Institute Miscellaneous Commercial ServicesCommercial Services Operates as a non-commercial research organization | Finanzdirektor/CFO | 01.05.2022 |
MiMedx, Inc.
 MiMedx, Inc. Medical SpecialtiesHealth Technology Develops orthopedic implant products | Finanzdirektor/CFO | 01.02.2016 |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | 01.08.2015 |
Deloitte Development LLC
 Deloitte Development LLC Miscellaneous Commercial ServicesCommercial Services Provides accounting, auditing and tax services | Comptroller/Controller/Auditor | 01.01.1999 |
Ausbildung von Mark Andersen
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
83
Beziehungen ersten Grades
9
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 9 |
|---|---|
Eli Lilly & Co.
 Eli Lilly & Co. Pharmaceuticals: MajorHealth Technology Manufactures, wholesales and markets pharmaceutical products | Health Technology |
MiMedx, Inc.
MiMedx, Inc. Medical SpecialtiesHealth Technology Develops orthopedic implant products | Health Technology |
Southern Utah University
 Southern Utah University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Lilly USA LLC
 Lilly USA LLC Pharmaceuticals: MajorHealth Technology Lilly USA LLC engages in the provision of pharmaceutical services. The company was founded on July 15, 2008 and is headquartered in Indianapolis, IN. | Health Technology |
Deloitte Development LLC
Deloitte Development LLC Miscellaneous Commercial ServicesCommercial Services Provides accounting, auditing and tax services | Commercial Services |
Stephen M. Ross School of Business
 Stephen M. Ross School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Indiana Biosciences Research Institute
Indiana Biosciences Research Institute Miscellaneous Commercial ServicesCommercial Services Operates as a non-commercial research organization | Commercial Services |
KPMG US LLP
 KPMG US LLP Miscellaneous Commercial ServicesCommercial Services Provides auditing and taxation services | Commercial Services |
FibroBiologics, Inc.
 FibroBiologics, Inc. BiotechnologyHealth Technology Develops and commercializes fibroblast-based cell therapies | Health Technology |
